TMPRSS2 and prostate carcinoma: To clarify the role of TMPRSS2-ERG in prostate cancer, a TMA containing material from 350 prostate cancer patients whereof 256 were managed with watchful waiting, was analyzed with ERG immunohistochemistry (IHC).